<DOC>
	<DOCNO>NCT01816854</DOCNO>
	<brief_summary>In prospective study , newly develop self-expanding nitinol stent evaluate treatment atherosclerotic lesion superficial femoral artery .</brief_summary>
	<brief_title>Endovascular Treatment Atherosclerotic Lesions SFA Using Sinus-superflex-635 Stent</brief_title>
	<detailed_description />
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<criteria>Patient must sign informed consent prior indexprocedure Patient must older 18 year Patient must compliant followup date 1 month 12 month Patients intermittent claudication ( Rutherford 23 ) critical limb ischemia ( Rutherford 45 ) Target lesion locate superficial femoral artery ( minimal 1 cm origin SFA minimal 1 cm edge patella ) Reference vessel diameter ≥4.5 ≤6.5 mm ( visual estimate ) Patients TASC A , B C lesion Diameter stenosis target lesion &gt; 50 % chronic occlusion Inflow artery free hemodynamically significant obstruction ( i.e . ≥50 % ) The popliteal artery ( outflow ) free hemodynamically significant obstruction ( i.e . ≥50 % ) At least 1 patent belowtheknee vessel ( anterior tibial artery , posterior tibial artery peroneal artery ) till ankle confirm baseline angiography Patients Rutherford 1 6 Patiens Serum creatinine &gt; 2.0 mg/dL renal dialysis Patient take esomeprazole omeprazole Patient pregnant Patient suffers acute limb ischemia define sudden decrease limb perfusion cause potential threat limb viability Target lesion cross guidewire Target lesion locate popliteal artery Patients nickeltitanium allergy Patients aneurysm superficial femoral artery popliteal artery Patients TASC D lesion Patients life expectancy &lt; 1 year Patients schedule elective nonvascular procedure within 3 month indexprocedure , vascular procedure allow within 3 month indexprocedure guarantee acetylic salicylic acid clopidogrel intake interrupted Patients previous bypass surgery SFA Patients intolerance antithrombotic medication ( acetylic salicylic acid , clopidogrel , ticlopidine , glycoprotein IIb/IIIa inhibitor , direct thrombin inhibitor , etc ) Patient premedicated acetylic salicylic acid ( least 80 mg/day ) 2 hour indexprocedure Patient premedicated clopidogrel ( 600 mg/day ) 2 hour indexprocedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>SFA ,</keyword>
	<keyword>stent ,</keyword>
	<keyword>endovascular</keyword>
	<keyword>Patient outcome</keyword>
</DOC>